13.10
0.00
(0.00%)
As of April 15 at 9:50:01 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
141,561
141,561
113,189
113,491
127,374
Investing Cash Flow
-24,693
-24,693
-29,726
-21,102
-11,486
Financing Cash Flow
-91,529
-91,529
-84,883
-70,304
-59,053
End Cash Position
179,210
179,210
153,872
152,641
129,490
Capital Expenditure
--
--
-29,726
-21,102
-11,486
Repayment of Debt
--
--
--
--
-4,500
Free Cash Flow
141,561
141,561
83,463
92,389
115,888
12/31/2021 - 2/7/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIOLQ Biolase Inc
0.0121
+21.00%
NPCE NeuroPace, Inc.
10.34
-3.09%
XAIR Beyond Air, Inc.
0.2299
-1.75%
MASS 908 Devices Inc.
4.4500
+0.68%
LUCD Lucid Diagnostics Inc.
1.1300
-5.04%
TNON Tenon Medical, Inc.
1.1300
-0.88%
BFLY Butterfly Network, Inc.
2.5200
0.00%
BJDX Bluejay Diagnostics, Inc.
2.3300
-0.43%
TMDX TransMedics Group, Inc.
87.18
+0.39%
RSLS ReShape Lifesciences Inc.
0.3800
-3.85%